Press Releases

MILWAUKEE--(BUSINESS WIRE)-- Rockwell Automation, Inc. (NYSE: ROK) will host its annual investor meeting on Thursday, November 15, in conjunction with the Company’s Automation Fair being held at the Pennsylvania Convention Center in Philadelphia. The video webcast portion of the meeting will begin at approximately 1:00 p.m. Eastern Time with presentations by Chairman and Chief Executive

DUBLIN--(BUSINESS WIRE)-- Horizon Pharma plc (Nasdaq: HZNP) today announced multiple presentations showing that people who have undergone a kidney transplant experience higher rates of uncontrolled gout compared to other renal disease patients, and mortality rates were higher in kidney transplant recipients diagnosed with gout. In addition, a retrospective analysis indicates that gout prevalence remains high am

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Sitka Biopharma is pleased to announce that Quark Venture Inc. and GF Securities, through their Global Health Sciences Fund (GHS), has invested $1.9M into Sitka – financing that will enable the company to complete critical GLP toxicology studies and GMP manufacture of clinical drug product. This in turn will allow Sitka and partner Cancer Research UK (CRUK) t

CHARLOTTE, N.C.--(BUSINESS WIRE)-- DNX Foods is partnering with the nation’s industry-leading distributor of nutritional and sports supplements and sports accessories,

WILMINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusive partnership with

RESTON, Va.--(BUSINESS WIRE)-- PMMI, The Association for Packaging and Processing Technologies, released its findings on automation’s impact on consumer packaged goods (CPG) companies. The organization’s new survey “Automation in CPG Companies” finds that as automation increases in importance and usability in the manufacturing sector, collaborative robots (cobots), artificial intelligenc

MINNEAPOLIS--(BUSINESS WIRE)-- Entrust Datacard, a leading provider of trusted identity and secure issuance technology solutions, today announced that the company has agreed to champion the Shakopee Public Schools Academy of Science and Technology. The Academies of Shakopee are small learning communities of students and teachers organized around areas of interest. Academy Champions mentor students and help give

WESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq:NDSN) announced today that Michael F. Hilton, President and Chief Executive Officer, will present at the Bair

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines to control the expression of genes, today announced that it will host a live conference call and webcast at 7:30 a.m. ET on Thursday, November 1, 2018 to report its third quarter 2018 financial results and provide a corporate update. To access the live conference call,

BONITA SPRINGS, Fla.--(BUSINESS WIRE)-- Herc Holdings Inc. (NYSE: HRI) will host a live webcast discussion of its 2018 third quarter and nine months financial results on Thursday, November 8, 2018, beginning at 8:30 a.m., U.S. Eastern Time. The Company plans to issue a press release with financial results prior to the call on Thursday. Shareholders and other interested parties may participate

DUBLIN--(BUSINESS WIRE)-- Opsona Therapeutics Ltd (‘Opsona’), today announces that it will give an oral presentation on results from its ongoing prospective, open label Phase I/II study being conducted with Tomaralimab (OPN-305), its novel proprietary humanized IgG4 monoclonal antibody (MAb) against Toll-Like Receptor 2 (TLR2), in second and third-line lower (Low and intermediate-1)

LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2018 financial res

CINCINNATI--(BUSINESS WIRE)-- Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that the Company will present renal function data obtained from the TIME-2 Phase 2 clinical trial of AKB-9778 in diabetic retinopathy patients at the American Society of Nephrology (ASN) Kidney Week 2018, Oct. 23-28, in San Dieg

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature a total of six

NIJMEGEN, Netherlands--(BUSINESS WIRE)-- NovioSense BV, the venture capital-backed clinical stage medical device company, today announced positive data from its NLNSGS2017-02 Phase 2 tear glucose sensor study. The NovioSense Glucose Sensor is a device that, when placed in the lower eyelid, continuously measures glucose levels in the tear fluid of diabetic patients. The results of the six-patient clinical trial